- Advertisement -

Anima Biotech Heads for the Light with Up-to-$2.4B Takeda Partnership

Anima specializes in treating targets long viewed as “undruggable” by targeting cellular mechanisms that regulate mRNA translation of proteins with specific biological roles in...

Results of pharmacokinetic analysis show Omomyc mini-protein maintains its structural integrity in tumor tissue for at least 72 hours following administration

Results of pharmacokinetic analysis show Omomyc mini-protein maintains its structural integrity in tumor tissue for at least 72 hours following administration Credit: VHIO Results of...

OXGENE launches a scalable, plasmid-free manufacturing system for AAV

Sep 23 2020 OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system...

The Unloved Biotechnology ETF Rally – ETF Trends

Biotechnology stocks have been outperforming over the past month, but ETF investors seem disinterested and are even trimming exposure to this sector. In a weekly...

Biotechnology draws $12.6B from private equity, venture capital activity in H1...

Biotechnology led the healthcare industry in investment activity from private equity and venture capital during the first half of 2020, drawing nearly $12.60 billion...

Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy

“These results argue that combinations based on immunotherapy may also provide an opportunity for targeting urothelial cancers with low TMB, and provide efficacy superior...

Tautomer-Predictor AI Tool Identifies Stable Molecules for Drug Discovery

New York University (NYU) researchers have trained an AI model to learn chemical patterns associated with stability in drug-like molecules and accurately predict where...

Biomimetic Nanoparticles Trigger Light Responses in Blind Mouse Retinas

Even after a retina loses its natural light-sensing cells, some of its nerve circuitry can remain intact. In a new preclinical study, researchers showed...

Tautomer-Predictor AI Tool Identifies Stable Molecules for Drug Discovery

New York University (NYU) researchers have trained an AI model to learn chemical patterns associated with stability in drug-like molecules and accurately predict where...

Biomimetic Nanoparticles Trigger Light Responses in Blind Mouse Retinas

Even after a retina loses its natural light-sensing cells, some of its nerve circuitry can remain intact. In a new preclinical study, researchers showed...

Advancing Cell Therapy for Cardiovascular Disease

Register Now Joshua Michael Hare, MD Founding Director,Interdisciplinary Stem Cell InstituteUniversity of MiamiMiller School of...

more new items

Tautomer-Predictor AI Tool Identifies Stable Molecules for Drug Discovery

New York University (NYU) researchers have trained an AI model to learn chemical patterns associated with stability in drug-like molecules and accurately predict where...

Biomimetic Nanoparticles Trigger Light Responses in Blind Mouse Retinas

Even after a retina loses its natural light-sensing cells, some of its nerve circuitry can remain intact. In a new preclinical study, researchers showed...

Advancing Cell Therapy for Cardiovascular Disease

Register Now Joshua Michael Hare, MD Founding Director,Interdisciplinary Stem Cell InstituteUniversity of MiamiMiller School of...